| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 66.611 | 89.578 | 92.093 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 66.611 | 89.578 | 92.097 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.211 | 15.361 | 31.495 | 43.896 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -2.211 | 51.250 | 58.083 | 48.200 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -2.211 | 50.119 | 57.233 | 42.355 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Urosab Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 10.859 | 7.935 | 23.811 |
| Current Assets | - | - | - | - | - | - | 178 | 46.831 | 45.334 | 36.924 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 32.309 | 33.603 | 32.350 |
| Cash | - | - | - | - | - | - | 178 | 14.522 | 11.732 | 4.574 |
| Shareholders Funds | - | - | - | - | - | - | -2.170 | 47.942 | 48.531 | 42.396 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.349 | 9.748 | 4.738 | 18.338 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urosab Med S.r.l.